V
Vincent Barlogis
Researcher at Aix-Marseille University
Publications - 31
Citations - 1140
Vincent Barlogis is an academic researcher from Aix-Marseille University. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 15, co-authored 31 publications receiving 917 citations. Previous affiliations of Vincent Barlogis include Boston Children's Hospital & Necker-Enfants Malades Hospital.
Papers
More filters
Journal ArticleDOI
DOCK8 Deficiency: Clinical and Immunological Phenotype and Treatment Options - a Review of 136 Patients
S. Aydin,Sara Sebnem Kilic,Caner Aytekin,Ashish R Kumar,Oscar Porras,Leena Kainulainen,Larysa Kostyuchenko,Ferah Genel,Necil Kutukculer,Neslihan Edeer Karaca,Luis Ignacio Gonzalez-Granado,Jordan K. Abbott,Daifulah Al-Zahrani,Nima Rezaei,Zeina Baz,Jens Thiel,Jens Thiel,Stephan Ehl,László Maródi,Jordan S. Orange,Julie Sawalle-Belohradsky,Sevgi Keles,Steven M. Holland,Ozden Sanal,Deniz Cagdas Ayvaz,Ilhan Tezcan,Hamoud Al-Mousa,Zobaida Alsum,Abbas Hawwari,Ayse Metin,Susanne Matthes-Martin,Manfred Hönig,Ansgar Schulz,Capucine Picard,Capucine Picard,Vincent Barlogis,Andrew R. Gennery,Marianne Ifversen,Joris M. van Montfrans,Taco W. Kuijpers,Robbert G. M. Bredius,Gregor Dückers,Waleed Al-Herz,Sung-Yun Pai,Sung-Yun Pai,Raif S. Geha,Gundula Notheis,Carl Philipp Schwarze,Betul Tavil,Fatih Mehmet Azik,Kirsten Bienemann,Bodo Grimbacher,Bodo Grimbacher,Valerie Heinz,H. Bobby Gaspar,Roland C. Aydin,Beate Hagl,Benjamin Gathmann,Bernd H. Belohradsky,Hans D. Ochs,Talal A. Chatila,Ellen D. Renner,Helen Su,Alexandra F. Freeman,Karin R. Engelhardt,Karin R. Engelhardt,Michael H. Albert +66 more
TL;DR: A comprehensive evaluation of the clinical phenotype of DOCK8 deficiency in the largest cohort reported so far demonstrates the severity of the disease with relatively poor prognosis and early HSCT should be strongly considered as a potential curative measure.
Journal ArticleDOI
Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients
Jean Donadieu,Marie Lamant,Claire Fieschi,Flore Sicre de Fontbrune,Aurélie Caye,Marie Ouachee,Blandine Beaupain,Jacinta Bustamante,Hélène Poirel,Bertrand Isidor,Eric Van Den Neste,Antoine Néel,Stanislas Nimubona,Fabienne Toutain,Vincent Barlogis,Nicolas Schleinitz,Thierry Leblanc,Pierre Rohrlich,Felipe Suarez,Dana Ranta,Wahid Abou Chahla,Bénédicte Bruno,Louis Terriou,Sylvie François,Bruno Lioure,Guido Ahle,Françoise Bachelerie,Claude Preudhomme,Eric Delabesse,Hélène Cavé,Christine Bellanné-Chantelot,Marlène Pasquet +31 more
TL;DR: Heterozygous germline GATA2 mutations strongly predispose to leukemia, immunodeficiency, and/or lymphoedema, and hematopoietic stem cell transplantation remains the best choice of treatment to avoid severe infectious and/ or hematologic complications.
Journal ArticleDOI
Epidemiology and outcome of invasive fungal diseases in patients with chronic granulomatous disease: a multicenter study in France.
Julien Beauté,Gaelle Obenga,Loïc Le Mignot,Nizar Mahlaoui,Marie-Elisabeth Bougnoux,Richard Mouy,Marie-Anne Gougerot-Pocidalo,Vincent Barlogis,Felipe Suarez,Fanny Lanternier,Olivier Hermine,Marc Lecuit,Stéphane Blanche,Alain Fischer,Olivier Lortholary +14 more
TL;DR: IFDs are a frequent and life-threatening complication in CGD patients and itraconazole significantly reduces its incidence and should be recommended in absence of better alternatives.
Journal ArticleDOI
Complications and treatment of patients with β-thalassemia in France: results of the National Registry.
Isabelle Thuret,Corinne Pondarré,Anderson Loundou,Dominique Steschenko,Robert Girot,Dora Bachir,Christian Rose,Vincent Barlogis,Jean Donadieu,Mariane de Montalembert,Isabelle Hagège,Brigitte Pegourie,Claire Berger,Marguerite Micheau,Françoise Bernaudin,Thierry Leblanc,Laurence Lutz,Frédéric Galactéros,Marie-Claude Simeoni,Catherine Badens +19 more
TL;DR: The rates of complications of iron overload in French thalassemia major patients appeared similar to those reported in other developed countries in which this condition is not endemic.
Journal ArticleDOI
Symptomatic osteonecrosis in childhood leukemia survivors: prevalence, risk factors and impact on quality of life in adulthood
Pauline Girard,Pascal Auquier,Vincent Barlogis,Audrey Contet,Maryline Poiree,Franç ois Demeocq,Julie Berbis,Iris Herrmann,Virginie Villes,Nicolas Sirvent,Justyna Kanold,Pascal Chastagner,Hervé Chambost,Dominique Plantaz,Gérard Michel +14 more
TL;DR: It is concluded that total and post-transplant cumulative steroid dose may predict the risk of osteonecrosis, a rare late effect with a strong negative impact on physical domains of Quality of Life.